Results 1 to 10 of about 6,692 (91)

Industrialization’s eye view on theranostic nanomedicine [PDF]

Frontiers in Chemistry, 2022
The emergence of nanomedicines (NMs) in the healthcare industry will bring about groundbreaking improvements to the current therapeutic and diagnostic scenario.
Maharajan Sivasubramanian, Li-Jie Lin, Yu-Chao Wang, Chung-Shi Yang, Leu-Wei Lo   +4 more
doaj   +2 more sources

Theranostic Nanomedicine for Malignant Gliomas [PDF]

Frontiers in Bioengineering and Biotechnology, 2019
Brain tumors mainly originate from glial cells and are classified as gliomas. Malignant gliomas represent an incurable disease; indeed, after surgery and chemotherapy, recurrence appears within a few months, and mortality has remained high in the last ...
Michele d'Angelo, Vanessa Castelli, Elisabetta Benedetti, Andrea Antonosante, Mariano Catanesi, Reyes Dominguez-Benot, Giuseppina Pitari, Rodolfo Ippoliti, Annamaria Cimini, Annamaria Cimini   +9 more
doaj   +2 more sources

Advancements and Perspectives in Polysaccharide-Based Nanoparticles for Theranostic Nanomedicine [PDF]

Pharmaceuticals, 2023
It is with great enthusiasm [...]
Jingdi Chen
doaj   +2 more sources

Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform [PDF]

Materials Today Bio, 2023
Exosomes have emerged as a promising cell-free therapeutic approach. However, challenges in large-scale production, quality control, and heterogeneity must be overcome before they can be used clinically.
Xiao Xu, Limei Xu, Caining Wen, Jiang Xia, Yuanmin Zhang, Yujie Liang   +5 more
doaj   +2 more sources

Corrigendum: Theranostic Nanomedicine for Malignant Gliomas [PDF]

Frontiers in Bioengineering and Biotechnology, 2020
Michele d'Angelo, Vanessa Castelli, Elisabetta Benedetti, Andrea Antonosante, Mariano Catanesi, Reyes Dominguez-Benot, Giuseppina Pitari, Rodolfo Ippoliti, Annamaria Cimini, Annamaria Cimini   +9 more
doaj   +2 more sources

Editorial: Advanced Theranostic Nanomedicine in Oncology [PDF]

Frontiers in Bioengineering and Biotechnology, 2020
Christos Tapeinos, Attilio Marino, Gianni Ciofani   +2 more
doaj   +2 more sources

Design of Experiments Leads to Scalable Analgesic Near-Infrared Fluorescent Coconut Nanoemulsions [PDF]

Pharmaceutics
Background: Pain is a complex phenomenon characterized by unpleasant experiences with profound heterogeneity influenced by biological, psychological, and social factors. According to the National Health Interview Survey, 50.2 million U.S.
Amit Chandra Das, Gayathri Aparnasai Reddy, Shekh Md. Newaj, Smith Patel, Riddhi Vichare, Lu Liu, Jelena M. Janjic   +6 more
doaj   +2 more sources

Theranostic nanomedicine: Potential therapeutic epitome

Journal of Advanced Pharmaceutical Technology & Research, 2015
Upendra Nagaich
doaj   +2 more sources

Harnessing nanomedicine to target NF-κB signalling in cancer: at the intersection of inflammatory signalling, metabolic reprogramming, and therapeutic innovation [PDF]

Cell Communication and Signaling
The nuclear factor kappa B (NF-κB) signalling pathway is a pivotal orchestrator of inflammation, tumour progression, immune modulation, and metabolic reprogramming within the dynamic landscape of the tumour microenvironment (TME).
Bandari BharathwajChetty, Babu Santha Aswani, Shweta S. Shinde, Mohammed S. Alqahtani, Mohamed Abbas, Gautam Sethi, Zhaowu Ma, Ajaikumar B. Kunnumakkara   +7 more
doaj   +2 more sources

Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives

Pharmaceuticals, 2022
Cardiovascular and related diseases (CVRDs) are among the most prevalent chronic diseases in the 21st century, with a high mortality rate. This review summarizes the various nanomedicines for diagnostic and therapeutic applications in CVRDs, including ...
Natasha Manners, Vishnu Priya, Abhishesh Kumar Mehata, Manoj Rawat, Syam Mohan, Hafiz A. Makeen, Mohammed Albratty, Ali Albarrati, Abdulkarim M. Meraya, Madaswamy S. Muthu   +9 more
doaj   +1 more source